The Social Security and National Insurance Trust (SSNIT) says it will strengthen its investment mix to build a sustainable ...

One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...

A particular Japanese car with Green inspiration is coming to us soon, as the Nissan Tekton is finally arriving in 2026! Its ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor ...

Helping plumbers, electricians, roofers and local service providers generate more leads through Google Maps and local ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...

StubHub (STUB 2.52%), the online event ticket purveyor, wasn't a golden ticket for investors in the weeks after its September ...

Why JDS Eyewear Is the Ideal Partner JDS Eyewear has nearly two decades of experience as a trusted China small batch ...

Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studiesBOSTON ...